ArticleClinical cancer research : an official journal of the American Association for Cancer Research2015

High-Dose Sirolimus and Immune-Selective Pentostatin plus Cyclophosphamide Conditioning Yields Stable Mixed Chimerism and Insufficient Graft-versus-Tumor Responses.

Miriam E Mossoba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.